申请人:Pfizer Inc.
公开号:US06077864A1
公开(公告)日:2000-06-20
A compound of the formula ##STR1## wherein n, X, Y and Ar are as defined herein, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, macular degeneration, restenosis, periodontal disease, epidermolysis bullosa, scleritis, and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock and other diseases involving the production of TNF. In addition, the compounds of the present invention may be used in combination therapy with standard non-steroidal anti-inflammatory drugs (NSAID'S) and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinum, etoposide, taxol, taxotere and other alkaloids, such as vincristine, in the treatment of cancer.
一种具有以下公式的化合物##STR1##其中n,X,Y和Ar如本文所定义,可用于治疗从以下组中选择的疾病:关节炎,癌症,组织溃疡,黄斑变性,再狭窄,牙周病,表皮松解症,巩膜炎和其他以基质金属蛋白酶活性为特征的疾病,艾滋病,败血症,感染性休克和其他涉及TNF产生的疾病。此外,本发明的化合物可以与标准的非甾体类抗炎药物(NSAID)和镇痛剂联合治疗,并与细胞毒性药物(如阿霉素,多柔比星,顺铂,依托泊苷,紫杉醇,替加氟和其他生物碱,如长春碱)联合使用,用于治疗癌症。